Ken Griffin Cooper Companies, Inc. Call Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$306.88 - $380.0 $5.59 Million - $6.92 Million	18,200 Added 62.33%	47,400 $17.9 Million
Q3 2023 Nov 14, 2023	BUY	$315.92 - $397.36 $4.26 Million - $5.36 Million	13,500 Added 85.99%	29,200 $9.29 Million
Q2 2023 Aug 14, 2023	SELL	$346.15 - $392.09 $865,375 - $980,224	-2,500 Reduced 13.74%	15,700 $6.02 Million
Q1 2023 May 15, 2023	BUY	$323.56 - $373.36 $2.52 Million - $2.91 Million	7,800 Added 75.0%	18,200 $6.8 Million
Q4 2022 Feb 14, 2023	BUY	$248.67 - $334.17 $2.59 Million - $3.48 Million	10,400 New	10,400 $3.44 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.